Type C RNA virus production and cell competence for normal differentiation in myeloid leukaemic cells.
D000956:Antigens, Viral / Q000032:analysis; D001665:Binding Sites; D002454:Cell Differentiation / Q000187:drug effects; D003115:Colony-Stimulating Factors / Q000494:pharmacology*; D003176:Complement C3 / Q000378:metabolism; D006023:Glycoproteins / Q000494:pharmacology*; D006098:Granulocytes / Q000166:cytology*; D006410:Hematopoiesis / Q000187:drug effects*; D007141:Immunoglobulin Fc Fragments; D009052:Leukemia Virus, Murine / Q000276:immunology; D007962:Leukocytes / Q000166:cytology*; D008264:Macrophages / Q000166:cytology*; D012194:RNA-Directed DNA Polymerase / Q000378:metabolism; D012190:Retroviridae / Q000502:physiology*; D014779:Virus Replication
D000956:Antigens, Viral; D003115:Colony-Stimulating Factors; D003176:Complement C3; D006023:Glycoproteins; D007141:Immunoglobulin Fc Fragments; D012194:RNA-Directed DNA Polymerase